NU-DERM SYSTEM NORMAL-DRY SKIN TRANSFORMATION- hydroquinone, octisalate and zinc oxide kit

Riik: Ameerika Ühendriigid

keel: inglise

Allikas: NLM (National Library of Medicine)

Osta kohe

Toote omadused Toote omadused (SPC)
19-01-2023

Toimeaine:

HYDROQUINONE (UNII: XV74C1N1AE) (HYDROQUINONE - UNII:XV74C1N1AE)

Saadav alates:

OBAGI COSMECEUTICAL LLC

Retsepti tüüp:

PRESCRIPTION DRUG

Näidustused:

For the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines and other unwanted areas of melanin hyperpigmentation. People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established. - helps prevent sunburn - If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Toote kokkuvõte:

Obagi Nu-Derm® Clear is available as follows: Net wt. 2 oz. (57 g) bottle NDC 62032-101-36 Obagi Nu-Derm Blender® is available as follows: Net wt. 2 oz. (57 g) bottle NDC 62032-100-36 Net wt. 1 oz. (28 g) bottle NDC 62032-100-10 Obagi Nu-Derm Sunfader® is available as follows: Net wt. 2 oz. (57 g) bottle NDC 62032-116-36 Store at controlled room temperature: 15° to 25°C (59° to 77°F). Keep out of direct sunlight. 1-800-636-7546

Volitamisolek:

unapproved drug other

Toote omadused

                                NU-DERM SYSTEM NORMAL-DRY SKIN TRANSFORMATION- HYDROQUINONE,
OCTISALATE AND ZINC OXIDE
OBAGI COSMECEUTICAL LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this_
_labeling has not been approved by FDA. For further information about
unapproved_
_drugs, click here._
----------
OBAGI NU-DERM SYSTEM
OBAGI NU-DERM
RX ONLY
FOR EXTERNAL USE ONLY
DESCRIPTION
Hydroquinone, USP 4% is 1, 4-benzenediol. The drug is freely soluble
in water and in
alcohol. Chemically, hydroquinone is designated as p-dihydroxybenzene;
the empirical
formula is C H O ; molecular weight is 110.11 g/mol. The chemical
structure is in the
diagram below.
EACH GRAM OF OBAGI NU-DERM CLEAR CONTAINS:
ACTIVE: Hydroquinone, USP 4% (40 mg/g)
INACTIVES: ascorbic acid, BHT, butylparaben, cetyl alcohol, disodium
EDTA, glycerin,
lactic acid, methylparaben, propylparaben, saponins, sodium lauryl
sulfate, sodium
metabisulfite, stearyl alcohol, tocopheryl acetate, water (aqua)
EACH GRAM OF OBAGI NU-DERM BLENDER CONTAINS:
ACTIVE: Hydroquinone, USP 4% (40 mg/g)
INACTIVES: ascorbic acid, BHT, cetyl alcohol, disodium EDTA, glycerin,
lactic acid,
methylparaben, phenyl trimethicone, PPG-2 myristyl ether propionate,
propylparaben,
saponins, sodium lauryl sulfate, sodium metabisulfite, TEA-salicylate,
tocopheryl acetate,
water (aqua)
®
®
6
6
2
®
®
®
®
EACH GRAM OF OBAGI NU-DERM SUNFADER CONTAINS:
ACTIVES: Hydroquinone, USP 4% (40mg/g); Octinoxate, USP 7.5%;
Oxybenzone, USP
5.5%
INACTIVES: ascorbic acid, BHT, butylparaben, cetyl alcohol, disodium
EDTA, glycerin,
methylparaben, propylparaben, saponins, sodium lauryl sulfate, sodium
metabisulfite,
stearyl alcohol, tocopheryl acetate, water (aqua)
CLINICAL PHARMACOLOGY
Topical application of hydroquinone produces a reversible
depigmentation of the skin by
inhibition of the enzymatic oxidation of tyrosine to 3,
4-dihydroxyphenylalanine (DOPA)
and suppression of other melanocyte metabolic processes. Exposure to
sunlight or
ultraviolet light will cause repigmentation of the bleached areas,

                                
                                Lugege kogu dokumenti